mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.009 |
0.8 |
mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.8 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.0087 |
0.8 |
mRNA |
BI-2536 |
FIMM |
pan-cancer |
AAC |
0.033 |
0.8 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
0.0073 |
0.8 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
0.0089 |
0.8 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.0086 |
0.8 |
mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0079 |
0.8 |
mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.8 |